Today, NIH released its implementation plan for driving gold standard science. NIH’s Gold Standard Science Implementation Plan outlines our key accomplishments to date and presents a transparent vision for the road ahead. To learn more and to access the plan, please see the statement issued today by NIH Director, Dr. Jay Bhattacharya. Questions may be sent to SciencePolicy@od.nih.gov. […]| Office of Science Policy
To maximize the value of NIH research grants, grantees should aim to utilize as much of their funds as possible for research activities. With this in mind, NIH has released a request for information (RFI) regarding policy options to maximize research funds by limiting allowable publication costs (APCs). Stakeholders are invited to provide feedback on […] The post NIH Releases Request for Information on Maximizing Research Funds by Limiting Allowable Publication Costs appeared fi...| Office of Science Policy
You may have recently heard the NIH Director speak about the importance of academic freedom in scientific discovery. In short, NIH defines academic freedom as the ability to engage in open, rigorous discourse to stress test ideas, challenge the status quo, and shape the most impactful path forward. Now, I might be biased – but […]| Office of Science Policy
The use of Artificial Intelligence (AI) tools can be helpful in limited aspects of preparing NIH research applications. However, it is critical to maintain the fairness and originality of NIH’s research application process. The rapid submission of large numbers of research applications from a single Principal Investigator (PI) may also unfairly strain NIH’s application review […] The post NIH Issues Policy to Support Originality and Fairness in Research Application Process appeared fi...| Office of Science Policy
Effective today, the NIH Public Access Policy is in effect and manuscripts accepted for publication in a journal on or after July 1, 2025, must be submitted to PubMed Central for public availability without embargo upon the official date of publication. To assist with compliance, NIH has developed a new website dedicated to the Public […]| Office of Science Policy
The National Institutes of Health (NIH) and the U.S. Food and Drug Administration (FDA) have published a new glossary of clinical research terms related to innovative clinical trial design, including studies using real-world data to generate real-world evidence. This glossary is intended to facilitate communication within the clinical research community by establishing a common vocabulary. […]| Office of Science Policy
Pursuant to the May 5, 2025, Executive Order on Improving the Safety and Security of Biological Research, NIH is requiring all NIH awardees to review their research portfolios to identify NIH funding and other support for projects meeting the definition of dangerous gain-of-function research. Review must be complete by June 30, 2025. NIH will also […]| Office of Science Policy
Summer is here! Like many of you, I have been counting down the days. In fact, I have been thinking so hard about summer, that I neglected to acknowledge a big milestone. My last post, in April, was the 100th Under the Poliscope blog! Since we missed the centennial, we are just going to have […]| Office of Science Policy
Institutional Biosafety Committees (IBCs) serve as a critical linchpin in ensuring the safe and responsible conduct of research. As such they are essential in building public trust on behalf of the biomedical research enterprise. Effective June 1, 2025, and as announced on March 28, 2025: To assist institutions, NIH has revised its FAQs on IBC […]| Office of Science Policy
NIH is committed to advancing novel AI approaches that have the potential to accelerate research and improve the health of the public. As such, NIH is seeking input from the public on how to develop and share new generative AI tools while maintaining the highest privacy protections for biomedical research participants. Comments on the RFI […]| Office of Science Policy
